OSR Holdings Inc (OSRH) Stock Analysis

Verdict: AVOID

Severe liquidity distress and widening losses (EPS -4.02) overshadow recent volume spikes, making the 0.16 current ratio a terminal risk.

Investment score: 32/100

Analysis as of

Is OSR Holdings Inc stock worth reviewing? AI model thesis

OSRH is a distressed micro-cap biotechnology firm with deteriorating fundamentals. Despite a flurry of trading activity, the company's financial structure is unsustainable without significant capital injection, and its operating losses have doubled year-over-year.

7-factor investment score

OSR Holdings Inc opportunities and risks

What speaks for OSRH

What speaks against OSRH

Peers and competitors

Trailing-twelve-month ratios
TickerP/EP/SEV/EBITDAGross marginNet marginFCF yield
OSRHn/a7.9xn/a-98.8%-836.9%-51.8%
KALAn/a0.0xn/a0.0%0.0%-149.9%
TPSTn/a0.0xn/a0.0%0.0%-121.2%
KTTAn/a0.0x8.0x0.0%0.0%-57154.1%
BCLIn/a0.0xn/a0.0%0.0%-26.1%
INTIn/a0.0xn/a0.0%0.0%-21.0%
Peer mediann/a0.0xn/a0.0%0.0%-121.2%

Frequently asked questions about OSR Holdings Inc (OSRH)

Is OSRH stock a good investment?

The cached TradeMates AI model rates OSR Holdings Inc as AVOID with an investment score of 32/100. OSRH is a distressed micro-cap biotechnology firm with deteriorating fundamentals. Despite a flurry of trading activity, the company's financial structure is unsustainable without significant capital injection, and its operating losses have doubled year-over-year. This is algorithmic model output, not personal investment advice.

Is OSRH stock a buy?

The TradeMates model verdict for OSRH is AVOID with an investment score of 32/100. Treat this as a model signal to review, not a personal buy recommendation.